DECITABINE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
75834-190 -
Package NDC
75834-190-01 -
Application number
ANDA212117 -
SPL ID
e20c2038-e61d-4c04-8b35-f2ff37a1b8d5 -
SPL set ID
150537a8-10ac-422d-bf33-68b1a408e566 -
UNII
776B62CQ27 -
RxCUI
636631
What the source publishes
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Active ingredients
- decitabine
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DECITABINE",
"splId": "e20c2038-e61d-4c04-8b35-f2ff37a1b8d5",
"labels": [
{
"setId": "150537a8-10ac-422d-bf33-68b1a408e566",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=150537a8-10ac-422d-bf33-68b1a408e566",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=150537a8-10ac-422d-bf33-68b1a408e566"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Nivagen Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 CARTON (75834-190-01) / 20 mL in 1 VIAL",
"package_ndc": "75834-190-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20201217"
}
],
"productId": "75834-190_e20c2038-e61d-4c04-8b35-f2ff37a1b8d5",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "75834-190",
"deaSchedule": null,
"genericName": "decitabine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DECITABINE",
"strength": "50 mg/20mL"
}
],
"applicationNumber": "ANDA212117",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20201217",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000233",
"N0000175595"
],
"upc": [
"0375834190013"
],
"unii": [
"776B62CQ27"
],
"rxcui": [
"636631"
],
"spl_set_id": [
"150537a8-10ac-422d-bf33-68b1a408e566"
],
"pharm_class_epc": [
"Nucleoside Metabolic Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleic Acid Synthesis Inhibitors [MoA]"
],
"manufacturer_name": [
"Nivagen Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:75834-190_e20c2038-e61d-4c04-8b35-f2ff37a1b8d5"